MAPT and amyloidosis: In sensitivity analyses using the early amyloid PET from the Biomarkers for Identifying Neurodegenerative Disorders Early and Reliably (BioFINDER) study and inferior temporal ROIs, all p-tau biomarkers were more closely associated with amyloid PET than tau PET (eResults, eFigure 1, and eTable 5 in the Supplement).